A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity

Παρόμοια τεκμήρια

• Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
  ανά: Coates, L, κ.ά.
  Έκδοση: (2020)
• Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
  ανά: Mease, P, κ.ά.
  Έκδοση: (2018)
• Methotrexate in psoriasis and psoriatic arthritis
  ανά: Coates, L, κ.ά.
  Έκδοση: (2020)
• Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
  ανά: Helliwell, PS, κ.ά.
  Έκδοση: (2022)
• Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
  ανά: Nash, P, κ.ά.
  Έκδοση: (2020)